This map shows the geographic impact of W R Crom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W R Crom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W R Crom more than expected).
This network shows the impact of papers produced by W R Crom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W R Crom. The network helps show where W R Crom may publish in the future.
Co-authorship network of co-authors of W R Crom
This figure shows the co-authorship network connecting the top 25 collaborators of W R Crom.
A scholar is included among the top collaborators of W R Crom based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W R Crom. W R Crom is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Houghton, Peter J., et al.. (1997). Probenecid alters topotecan (TPT) systemic and renal disposition. Clinical Pharmacology & Therapeutics. 61(2).1 indexed citations
Kearns, Christine M., Raymond L. Blakley, Victor M. Santana, & W R Crom. (1994). Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.. PubMed. 54(5). 1235–9.46 indexed citations
9.
Rodman, John H., Mary V. Relling, Clinton F. Stewart, et al.. (1993). Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children.. PubMed. 20(1). 18–29.33 indexed citations
Hurwitz, Craig A., Robert A. Krance, MJ Schell, et al.. (1992). Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.. PubMed. 6 Suppl 2. 39–43.13 indexed citations
12.
Gregory, R E, Ching‐Hon Pui, & W R Crom. (1991). Raised plasma methotrexate concentrations following intrathecal administration in children with renal dysfunction.. PubMed. 5(11). 999–1003.8 indexed citations
Crom, W R, et al.. (1983). Cisplatin-induced changes in bleomycin elimination.. PubMed. 67(6). 587–9.13 indexed citations
17.
Stewart, Clinton F., W R Crom, & Paul Bowman. (1982). Influence of serum concentration on renal clearance of methotrexate in children with acute lymphocytic leukemia. Annals of Pharmacotherapy. 16(6).2 indexed citations
18.
Cb, Pratt, et al.. (1982). Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.. PubMed. 65(11-12). 1021–6.31 indexed citations
19.
Evans, William E., et al.. (1980). Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.. PubMed. 26(13). 1902–4.47 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.